Expert for Engineered Cells, Miltenyi Biotec
BIOGRAPHY
Speaker
Event Date & Time
DATE: November 13, 2019
TIME: 12:00pm PST
Abstract
NK cells play a major role in immune surveillance and in the early immune response to cancer and infections. Beneficial anti-tumor responses have been observed, illustrating the safety profile and clinical potential of this treatment. With an increasing availability of anti-cancer drugs, the role of NK cell-based approaches in novel combination therapies has rapidly escalated.
Learning Objectives:
- Identify the latest trends on the NK cell immuno-oncology field
- Identify the tools you need to successfully push your basic research to the next level
- Describe how to seamlessly translate your basic research into clinical settings
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...